Discovery of novel N-1 substituted pyrazolopyrimidinones as potent, selective PDE2 inhibitors
Year: 2021
Type: article
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3161802304
